Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis.
about
Secukinumab for rheumatology: development and its potential place in therapyAberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritisElevated Ratio of Th17 Cell-Derived Th1 Cells (CD161(+)Th1 Cells) to CD161(+)Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis PatientsRatio of Circulating IFNγ (+) "Th17 Cells" in Memory Th Cells Is Inversely Correlated with the Titer of Anti-CCP Antibodies in Early-Onset Rheumatoid Arthritis Patients Based on Flow Cytometry Methods of the Human Immunology ProjectMechanistic rationales for targeting interleukin-17A in spondyloarthritis.Selected cytokine pathways in rheumatoid arthritis.Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practiceThe role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid ArthritisAlteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study.Identification of HLA-DRB1 association to adalimumab immunogenicity.
P2860
Q26738523-FB344CB1-1C45-403E-B0C5-482996B4E99FQ33827644-485FD43E-E063-41AB-BFCC-AAAEE64B3E93Q36270103-E0294B24-E396-4A0A-8A1E-5F2E2EDAB280Q36792701-A417D5D3-F8B0-475C-B702-74CF4ABA37AEQ36936735-694EB011-FD42-4EAB-A21F-6C6D2E2D221EQ37686009-220A00A5-3561-42C4-AF4D-036A0F89D649Q38755912-C9BA1037-3A6B-4622-A3EA-DFD4636C7E34Q38815234-B0F43761-3B12-4633-897D-BC1DE89272EEQ38883893-031ABA36-348C-4473-8DD2-FFBE60032087Q39015080-C0BD51CA-914E-414C-B027-B9185F1BA3FCQ39153776-40546179-AFE9-43D8-8198-865853C94E6BQ39215645-06694E93-4959-4252-9BF6-B3E635FD9352Q39429529-3E283B9E-873A-442E-B883-B2949547F3B6Q47108321-771712EA-DBF7-4699-8F98-1B54879C138EQ48219239-DE860CF6-E495-43DC-B851-05EC01A93432Q55284744-5DB17CED-8EF0-46E9-B72B-F008F219CD7B
P2860
Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@en
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@nl
type
label
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@en
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@nl
prefLabel
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@en
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@nl
P2093
P2860
P356
P1433
P1476
Association of HLA-DRB1 allele ...... n active rheumatoid arthritis.
@en
P2093
Anni Agarwal Berneis
David M Lee
Galina Shestakova
Hendrik Schulze-Koops
Irina Koroleva
Mark C Genovese
Patrick Durez
Steve Lewitzky
Wolfgang Hueber
Ying A Wang
P2860
P356
10.1093/RHEUMATOLOGY/KEV258
P577
2015-08-12T00:00:00Z